Literature DB >> 7509278

Specific CD45 isoforms differentially regulate T cell receptor signaling.

D Chui1, C J Ong, P Johnson, H S Teh, J D Marth.   

Abstract

Multiple isoforms of T cell CD45 tyrosine phosphatase are expressed as a result of alternative RNA splicing among extracellular exons. To discern the presence and identity of distinct functions among CD45 isoforms, we compared thymic T cell activation responses by elevating expression of two CD45 isoforms normally found on quiescent T cells. We report that CD45RABC significantly increased CD4+ thymic T cell proliferation in both a mixed lymphocyte reaction and following anti-T cell receptor (TCR) antibody stimulation. Additionally, CD45RABC enhanced Ca2+ mobilization and phosphotyrosine accumulation, and suppressed the inhibitory effect of anti-CD4 antibodies. By contrast, CD45R0 did not enhance TCR signaling or phosphotyrosine levels in CD4+ thymic T cells and required a TCR co-stimulus to augment cellular proliferation. These studies provide genetic evidence that alternative CD45 isoforms are functionally distinct and disclose a unique mechanism by which T cell immunologic responsiveness can be modified.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7509278      PMCID: PMC394878          DOI: 10.1002/j.1460-2075.1994.tb06322.x

Source DB:  PubMed          Journal:  EMBO J        ISSN: 0261-4189            Impact factor:   11.598


  61 in total

1.  Expression of variable exon A-, B-, and C-specific CD45 determinants on peripheral and thymic T cell populations.

Authors:  K S Hathcock; G Laszlo; H B Dickler; S O Sharrow; P Johnson; I S Trowbridge; R J Hodes
Journal:  J Immunol       Date:  1992-01-01       Impact factor: 5.422

2.  A functional complex is formed in human T lymphocytes between the protein tyrosine phosphatase CD45, the protein tyrosine kinase p56lck and pp32, a possible common substrate.

Authors:  B Schraven; H Kirchgessner; B Gaber; Y Samstag; S Meuer
Journal:  Eur J Immunol       Date:  1991-10       Impact factor: 5.532

Review 3.  CD45: a leukocyte-specific member of the protein tyrosine phosphatase family.

Authors:  I S Trowbridge; H L Ostergaard; P Johnson
Journal:  Biochim Biophys Acta       Date:  1991-10-16

4.  Coassociation of CD26 (dipeptidyl peptidase IV) with CD45 on the surface of human T lymphocytes.

Authors:  Y Torimoto; N H Dang; E Vivier; T Tanaka; S F Schlossman; C Morimoto
Journal:  J Immunol       Date:  1991-10-15       Impact factor: 5.422

5.  Antigens displayed on murine B lymphocyte precursors.

Authors:  P W Kincade; G Lee; T Watanabe; L Sun; M P Scheid
Journal:  J Immunol       Date:  1981-12       Impact factor: 5.422

6.  The zeta chain is associated with a tyrosine kinase and upon T-cell antigen receptor stimulation associates with ZAP-70, a 70-kDa tyrosine phosphoprotein.

Authors:  A C Chan; B A Irving; J D Fraser; A Weiss
Journal:  Proc Natl Acad Sci U S A       Date:  1991-10-15       Impact factor: 11.205

7.  Direct activation of calcium-activated, phospholipid-dependent protein kinase by tumor-promoting phorbol esters.

Authors:  M Castagna; Y Takai; K Kaibuchi; K Sano; U Kikkawa; Y Nishizuka
Journal:  J Biol Chem       Date:  1982-07-10       Impact factor: 5.157

8.  DNL 1.9: a monoclonal antibody which specifically detects all murine B lineage cells.

Authors:  D S Dessner; M R Loken
Journal:  Eur J Immunol       Date:  1981-04       Impact factor: 5.532

9.  Interspecies spleen-myeloma hybrid producing monoclonal antibodies against mouse lymphocyte surface glycoprotein, T200.

Authors:  I S Trowbridge
Journal:  J Exp Med       Date:  1978-07-01       Impact factor: 14.307

10.  Activation events during thymic selection.

Authors:  A Bendelac; P Matzinger; R A Seder; W E Paul; R H Schwartz
Journal:  J Exp Med       Date:  1992-03-01       Impact factor: 14.307

View more
  11 in total

1.  Epitope-specific crosslinking of CD45 down-regulates membrane-associated tyrosine phosphatase activity and triggers early signalling events in human activated T cells.

Authors:  François Spertini; Veronique Perret-Menoud; Nathalie Barbier; Talal Chatila; Catherine Barbey; Blaise Corthesy
Journal:  Immunology       Date:  2004-12       Impact factor: 7.397

Review 2.  CD45: all is not yet crystal clear.

Authors:  Nick Holmes
Journal:  Immunology       Date:  2006-02       Impact factor: 7.397

3.  CD45 enhances positive selection and is expressed at a high level in large, cycling, positively selected CD4+CD8+ thymocytes.

Authors:  C J Ong; J P Dutz; D Chui; H S Teh; J D Marth
Journal:  Immunology       Date:  1997-05       Impact factor: 7.397

Review 4.  Regulation of cell signaling by the protein tyrosine phosphatases, CD45 and SHP-1.

Authors:  T Ulyanova; J Blasioli; M L Thomas
Journal:  Immunol Res       Date:  1997-02       Impact factor: 2.829

5.  Structural and functional analysis of the human CD45 gene (PTPRC) upstream region: evidence for a functional promoter within the first intron of the gene.

Authors:  M Timón; P C Beverley
Journal:  Immunology       Date:  2001-02       Impact factor: 7.397

6.  Cord blood CD4+ CD45RA+ T cells achieve a lower magnitude of activation when compared with their adult counterparts.

Authors:  J Hassan; D J Reen
Journal:  Immunology       Date:  1997-03       Impact factor: 7.397

7.  Branched O-linked oligosaccharides ectopically expressed in transgenic mice reduce primary T-cell immune responses.

Authors:  S Tsuboi; M Fukuda
Journal:  EMBO J       Date:  1997-11-03       Impact factor: 11.598

8.  9-O-Acetylation of sialomucins: a novel marker of murine CD4 T cells that is regulated during maturation and activation.

Authors:  M Krishna; A Varki
Journal:  J Exp Med       Date:  1997-06-02       Impact factor: 14.307

Review 9.  The human immunodeficiency virus type 1 (HIV-1) CD4 receptor and its central role in promotion of HIV-1 infection.

Authors:  S Bour; R Geleziunas; M A Wainberg
Journal:  Microbiol Rev       Date:  1995-03

10.  In vitro reconstitution of T cell receptor-mediated segregation of the CD45 phosphatase.

Authors:  Catherine B Carbone; Nadja Kern; Ricardo A Fernandes; Enfu Hui; Xiaolei Su; K Christopher Garcia; Ronald D Vale
Journal:  Proc Natl Acad Sci U S A       Date:  2017-10-17       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.